|
391 |
Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus
Enthalten in Clinical proteomics Bd. 14, 21.6.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
392 |
Distribution and symmetrical patellofemoral pain patterns as revealed by high-resolution 3D body mapping: a cross-sectional study
Enthalten in BMC musculoskeletal disorders Bd. 18, 18.4.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
393 |
DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis
Enthalten in Arthritis Research & Therapy Bd. 19, 29.3.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
394 |
Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
Enthalten in Arthritis Research & Therapy Bd. 19, 26.4.2017, Nr. 1, date:12.2017: 1-8
|
|
|
|
395 |
Does rheumatoid synovitis activity vary during the day? Evaluation with color doppler sonography
Enthalten in BMC musculoskeletal disorders Bd. 18, 4.3.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
396 |
Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4+ T cells in systemic lupus erythematosus
Enthalten in Clinical epigenetics Bd. 9, 22.9.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
397 |
Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis
Enthalten in Journal of pharmaceutical health care and sciences Bd. 3, 19.1.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
398 |
Dynamic arm study: quantitative description of upper extremity function and activity of boys and men with duchenne muscular dystrophy
Enthalten in Journal of neuroEngineering and rehabilitation Bd. 14, 26.5.2017, Nr. 1, date:12.2017: 1-14
|
|
|
|
399 |
Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis
Enthalten in BMC musculoskeletal disorders Bd. 18, 30.5.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
400 |
Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor decreases end-stage osteoarthritis pain and peripheral neuropathy in mice
Enthalten in Arthritis Research & Therapy Bd. 19, 25.5.2017, Nr. 1, date:12.2017: 1-9
|
|
Administration
